Goldman Sachs’s NeueHealth NEUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,080
Closed -$36.7K 6124
2023
Q1
$36.7K Sell
2,080
-648
-24% -$33.4K ﹤0.01% 5593
2022
Q4
$142K Buy
2,728
+135
+5% +$9.81K ﹤0.01% 5402
2022
Q3
$217K Buy
2,593
+363
+16% +$48.2K ﹤0.01% 5442
2022
Q2
$324K Buy
2,230
+848
+61% +$123K ﹤0.01% 5376
2022
Q1
$213K Sell
1,382
-402
-23% -$89.3K ﹤0.01% 5848
2021
Q4
$491K Sell
1,784
-3,314
-65% -$1.53M ﹤0.01% 5406
2021
Q3
$3.33M Sell
5,098
-10,144
-67% -$8.92M ﹤0.01% 3722
2021
Q2
$20.9M Buy
+15,242
New +$20.9M ﹤0.01% 2011

Other funds holding NEUE

Goldman Sachs's NEUE Position: Q2 2023 in Review

Goldman Sachs sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 2,080 shares — an estimated $36.7K sold.

Goldman Sachs first reported a position in NEUE in Q2 2021 and held it in 8 quarters. The position peaked at $20.9M in Q2 2021. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • Goldman Sachs reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 2,080 NeueHealth shares in Q2 2023, an estimated $36.7K.
  • Goldman Sachs first reported a position in NeueHealth in Q2 2021 and held it in 8 quarters.
  • Goldman Sachs's NeueHealth position peaked at $20.9M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.